Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Yeah, I think I would be in the long term camp and appreciate...

First 962 Last

Share
Profile

Follow
Tyrannomorus

243 Posts.

130

07/09/23

11:23

Post #: 69767081
Share

Originally posted by thevinnys: ↑

I would just like to add that all investors do not need to be aligned in their thinking.
We can all make investments without being judged by other posters here.

On that point, it is clear that this BOD is more closely aligned with "Market Cap" investors than "Share Price" Investors.

While many investors understandably focus on short-term share price movements, it's equally important to appreciate companies that prioritize a long-term vision and the development of robust pipelines.

Incannex has shown a distinct commitment to its long-term vision. As such the (BOD) appears to be more aligned with the Market Cap Investors' philosophy.

1. Emphasis on Pipeline Development:
Incannex has made it clear that its primary goal is to create long-term shareholder value through the development of a robust pipeline of innovative pharmaceuticals. This focus on research, development, and innovation positions them for substantial growth in the years to come.

2. Learning from Successful Takeovers:
Incannex's BOD seems to be taking a page from successful biopharma takeovers, such as the Jazz Pharmaceuticals acquisition of GW Pharma for a staggering $7 billion. This serves as a clear indication that Incannex is determined to build a valuable portfolio of pharmaceutical assets that could attract the attention of major players in the industry. (Re-domiciling to the USA is core to this strategy)

3. Resilience in the Face of Short-Term Fluctuations:
As Market Cap Investors, Incannex's leadership appears less swayed by short-term share price volatility. They understand that the development of groundbreaking pharmaceuticals often takes time, and they are prepared to weather market turbulence in pursuit of their long-term objectives.

While short-term share price movements are undoubtedly of interest to many investors, it's crucial to recognize that companies like Incannex play a vital role in advancing medical science and creating substantial shareholder value over time.

By aligning with their vision and supporting their efforts, we, as investors, can participate in a journey that extends beyond daily market fluctuations.

So, let's keep an eye on the Market Cap and our peers as the BOD continues to build out its promising pipelines, and remember that sometimes the most rewarding investments are those with a long-term horizon. Having attended the Brisbane Meeting I am still convinced that the BOD has the same motivation as detailed in this article published 2 years ago. Click to view the Article

Good luck to all holders (short-term & LTH)

Expand

Yeah, I think I would be in the long term camp and appreciate the commitment of the BOD to see this through. That's not to say that the share has price has no impact, and I would be lying if I said it didn't.

Interestingly, it was points 1, 2, 3 and 4 that spoke to me more. It's funny how we all look at the same thing, but see different things.

'Johnson said that psychedelics' ability to treat such a wide range of disorders is “unheard of.” Conditions alleviated include depression, anorexia, addiction, obsessive compulsive disorder, and PTSD — to name a few.' - 100% true IMO

Although psychedelics won't be to everyones taste, they sure would be able to help a hell of a lot of people.

IHL Price at posting: 7.2¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

RCE

Recce's R327 found effective against E.coli during clinical trial

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

There are more pages in this discussion • 267 more messages in this thread...

First 962 Last

Add IHL (ASX) to my watchlist

SPONSORED BY